Dr. Claire K. Mulvey, MD

Dr. Mulvey practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Mulvey's NPI, 1962845198, was assigned on April 8, 2013. Dr. Mulvey graduated from Perelman School of Medicine - Philadelphia in 2013. Dr. Mulvey holds California license A134616.

Dr. Mulvey's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Mulvey's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. Dr. Mulvey is also affiliated with MarinHealth Medical Center. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Mulvey to 4 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mulvey practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Mulvey's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Mulvey is board certified in internal medicine by the American Board of Internal Medicine. Dr. Mulvey is licensed in California.

Dmand AI lists chronic anemia and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Mulvey treats.

CMS data shows 854 Medicare services from Dr. Mulvey across 5 procedure codes in 2024, for 151 Medicare patients. Medicare paid $65,484 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 151 Medicare patients who saw Dr. Mulvey in 2024. The largest group is 65 to 74, with 74 patients. 75% of them have cancer, and 74% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mulvey's median patient age at 72, with 56% women.

In 2024, Dr. Mulvey wrote 333 Medicare Part D claims for 65 patients. 68% of them were for generic drugs. CMS names the drug for 160 of them, across 4 drugs with 11 or more claims each, at $917,662 in total drug cost. In 2023, CMS named 120 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Mulvey for performance year 2024, reported as part of a group. Dr. Mulvey accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mulvey as offering telehealth.

Dmand AI links 28 papers to Dr. Mulvey, published from 2012 to 2024. 2013 was the busiest year, with 7. The most frequent topics are Neuroendocrine Tumors, Diabetes Mellitus, Type 2 and Calcinosis. Dr. Mulvey has published most often in Atherosclerosis. Dr. Mulvey's most frequent co-authors are Muredach P. Reilly, MD, Emily K. Bergsland, MD and Atif Nazier Qasim, MD.

CMS Open Payments shows 6 general payments to Dr. Mulvey from 4 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 76% of the total. Genentech, Inc. paid the most, $2,449.

Dr. Mulvey graduated from Perelman School of Medicine - Philadelphia in 2013.

Dr. Mulvey is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.